Although further studies are still needed, reducing the levels of apoC-III, FABP4 and liver fat would prevent the changes in HDL component and help to ameliorate HDL-C metabolism, especially in obesity and insulin resistance [49]. Here, FABP4 is linked to obesity due to melanocortin 4 receptor deficiency.